Novartis AG (ADR) news

   Watch this stock
Showing stories 1 - 10 of about 154   

Articles published

NVS 75.97 -0.84 (-1.09%)
price chart
Novartis AG (ADR) (NYSE:NVS): Big Market Mover
[Market Realist] Novartis AG (ADR) (NYSE:NVS)(TREND ANALYSIS) reported a rise of ~1% in its revenue on a constant currency basis in its 1Q16 earnings.
Novartis AG (ADR) (NYSE:NVS) To Pay $25 Million Over Bribery Allegations
Last year GlaxoSmithKline plc (ADR) (NYSE:GSK) posted a 17% drop in sales as a state-led campaign on drug prices affected returns.
Novartis AG (ADR) (NYSE:NVS) Doles Out Over $25 Million In The Wake Of ...  Sonoran Weekly Review
Novartis AG (ADR) Under Pressure on Q1 Revenue Decline
Novartis AG (ADR) (NYSE:NVS) has reported financial results for the first quarter of fiscal year 2016 (1QFY16) with a decline in both, its earnings and revenues.
Bimagrumab (BYM338) drug from Novartis AG (ADR) (NYSE:NVS) Failed a Phase IIb ...
Bimagrumab (BYM338) from Novartis AG (ADR) (NYSE:NVS) failed a Phase IIb/III study. The news of the failure of the study pertaining to a rare, muscle-wasting disease known as sporadic inclusion body myositis was heartbreaking for the pharma giant since ...
Novartis AG (ADR) First-Quarter Earnings: What to Expect?
Novartis AG (ADR) (NYSE:NVS) is set to announce its financial results for the first quarter of 2016 (1Q) on Thursday, April 21.
HC Stocks Reports Analysis: Novartis AG (ADR) (NVS), Pfizer Inc. (PFE), Sanofi ...
Shares of Novartis AG (ADR) (NYSE:NVS) ended Thursday session in red amid volatile trading. The shares closed down -0.17 points or -0.22% at $76.81 with 2.26M shares getting traded.
Analysts Review: Novartis AG (ADR) (NYSE:NVS)
Novartis AG (ADR) (NYSE:NVS) received “Downgrade” rating by Morgan Stanley in a research note issued to investors on Apr-12-16 from Equal-Weight to Underweight.
Why Novartis AG (ADR) have been downgraded?  CWRU Observer
Insiders Are Buying These Shares: Novartis AG (ADR) (NYSE:NVS), Consolidated ...  iStreetWire
Will Teva Pharmaceutical Industries Ltd (ADR) (NYSE:TEVA) And Novartis AG (ADR ...
It is not clear whether Teva's Pharmaceutical Industries Ltd (ADR) (NYSE:TEVA) and Novartis AG (ADR)(NYSE:NVS) are trying to fend off copy cats.
Citigroup Downgrades Novartis AG (ADR) to Neutral  Street Edition
Amgen, Inc. (NASDAQ:AMGN) Has Sued Novartis' AG (ADR) (NYSE:NVS) Sandoz Unit ...
Top-selling anti-inflammatory drug Enbrel from Amgen, Inc. (NASDAQ:AMGN) is facing steep competition from biosimilars that are hitting the market at a very rapid speed.
Amgen Inc to Face Off Pfizer & Novartis to Save Key Drugs  Bidness ETC
Novartis AG (ADR) Plunges on Profit Miss
Novartis AG (ADR) (NYSE:NVS) reported lower-than-expected fourth quarter and full year earnings data for fiscal 2015 today, driven mostly by its struggling eye-care business and strengthened dollar.
Novartis (NVS) Posts Lower-Than-Expected Earnings in Q4  Nasdaq
Novartis and the 'T' Word  Bloomberg